LONDON and NEW YORK, Jan. 23, 2026), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseas ...
38m
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...
1d
Kugler Vision Publishes SMILE vs LASIK Comparison for Patients Exploring Vision Correction Options
OMAHA, NE - January 21, 2026 - PRESSADVANTAGE - Kugler Vision has released a new educational article titled "SMILE vs ...
When our practice adopted the Light Adjustable Lens in 2022, we did so with a clear purpose of helping patients with corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback